|
GDI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.618200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.94600000000112E-05 |
| Normal-vs-Stage2 |
6.223600E-02 |
| Normal-vs-Stage3 |
2.099000E-01 |
| Normal-vs-Stage4 |
3.940600E-01 |
| Stage1-vs-Stage2 |
5.459800E-01 |
| Stage1-vs-Stage3 |
2.283400E-01 |
| Stage1-vs-Stage4 |
2.274000E-01 |
| Stage2-vs-Stage3 |
7.150600E-01 |
| Stage2-vs-Stage4 |
4.861800E-01 |
| Stage3-vs-Stage4 |
7.707000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44820000000679E-05 |
| Normal-vs-AfricanAmerican |
9.275600E-02 |
| Normal-vs-Asian |
8.214400E-01 |
| Caucasian-vs-AfricanAmerican |
1.641590E-01 |
| Caucasian-vs-Asian |
2.911400E-01 |
| AfricanAmerican-vs-Asian |
6.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38569999999605E-05 |
| Normal-vs-Female |
5.371000E-01 |
| Male-vs-Female |
4.378900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.225900E-04 |
| Normal-vs-Extreme_Weight |
2.86469999999373E-06 |
| Normal-vs-Obese |
2.036100E-02 |
| Normal-vs-Extreme_Obese |
3.438500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.895800E-01 |
| Normal_Weight-vs-Obese |
1.676830E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.869600E-01 |
| Extreme_Weight-vs-Obese |
4.515600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.556000E-01 |
| Obese-vs-Extreme_Obese |
2.256400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.350400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.798100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.92551000000041E-05 |
| Normal-vs-Age(81-100Yrs) |
1.424910E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.726200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.291900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.400000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.341600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.911400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.167000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.62010000000135E-05 |
| Normal-VS-Type2 PRCC |
4.280100E-02 |
| Normal-VS-KIRP CIMP |
5.668800E-01 |
| Normal-VS-Unclassified PRCC |
9.657900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.196360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.548100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.554400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.892210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.507200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.915150E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.597800E-03 |
| Normal-vs-N1 |
8.504800E-01 |
| Normal-vs-N2 |
7.116400E-01 |
| N0-vs-N1 |
5.315700E-02 |
| N0-vs-N2 |
6.039200E-01 |
| N1-vs-N2 |
7.019800E-01 |
|
|
